
|Articles|August 1, 2004
FDA approves Botox for hyperhidrosis tx
Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
2
Study Suggests Non-Ablative Fractional Laser Reverses Epigenetic Signatures of Skin Aging
3
Phase 2 Trial Supports Oral VDPHL01 for Female Pattern Hair Loss
4
DNA Methylation Changes Tied to Laser Skin Resurfacing
5












